AI assistant
CONMED Corp — Director's Dealing 2019
Jun 4, 2019
31971_dirs_2019-06-04_3b323d75-33cd-4167-b1b7-36cb2adb5e69.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-05-31
Reporting Person: Farkas Charles (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-31 | Common Stock | M | 1629 | — | Acquired | 15503 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-31 | Rsus (restricted Stock Units) | $0 | M | 1629 | Disposed | 2028-06-01 | Common Stock (1629) | Direct |
| 2019-06-03 | Rsus (restricted Stock Units) | $0 | A | 1407 | Acquired | 2029-06-03 | Common Stock (1407) | Direct |
| 2019-06-03 | Options To Purchase Common Stock | $79.94 | A | 2165 | Acquired | 2029-06-03 | Common Stock (2165) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.